177 related articles for article (PubMed ID: 24321200)
1. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
[TBL] [Abstract][Full Text] [Related]
2. The role of GRIK4 gene in treatment-resistant depression.
Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
[TBL] [Abstract][Full Text] [Related]
3. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
[TBL] [Abstract][Full Text] [Related]
4. The role of the potassium channel gene KCNK2 in major depressive disorder.
Congiu C; Minelli A; Bonvicini C; Bortolomasi M; Sartori R; Maj C; Scassellati C; Maina G; Trabucchi L; Segala M; Gennarelli M
Psychiatry Res; 2015 Feb; 225(3):489-92. PubMed ID: 25535009
[TBL] [Abstract][Full Text] [Related]
5. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
6. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
[TBL] [Abstract][Full Text] [Related]
7. Harm avoidance involved in mediating the association between nerve growth factor (NGF) gene polymorphisms and antidepressant efficacy in patients with major depressive disorder.
Yeh YW; Kuo SC; Chen CY; Liang CS; Ho PS; Yen CH; Chen TY; Shyu JF; Wan FJ; Lu RB; Huang SY
J Affect Disord; 2015 Sep; 183():187-94. PubMed ID: 26021968
[TBL] [Abstract][Full Text] [Related]
8. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
[TBL] [Abstract][Full Text] [Related]
9. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Calati R; Crisafulli C; Balestri M; Serretti A; Spina E; Calabrò M; Sidoti A; Albani D; Massat I; Höfer P; Amital D; Juven-Wetzler A; Kasper S; Zohar J; Souery D; Montgomery S; Mendlewicz J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():271-8. PubMed ID: 23537502
[TBL] [Abstract][Full Text] [Related]
12. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
[TBL] [Abstract][Full Text] [Related]
13. The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study.
Yang C; Nolte IM; Ma Y; An X; Bosker FJ; Li J
Mol Genet Genomic Med; 2021 Sep; 9(9):e1752. PubMed ID: 34355541
[TBL] [Abstract][Full Text] [Related]
14. MTHFR: Genetic variants, expression analysis and COMT interaction in major depressive disorder.
Gabriela Nielsen M; Congiu C; Bortolomasi M; Bonvicini C; Bignotti S; Abate M; Milanesi E; Conca A; Cattane N; Tessari E; Gennarelli M; Minelli A
J Affect Disord; 2015 Sep; 183():179-86. PubMed ID: 26021967
[TBL] [Abstract][Full Text] [Related]
15. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
[TBL] [Abstract][Full Text] [Related]
16. IL6-174G > C genetic polymorphism influences antidepressant treatment outcome.
Carvalho S; Santos M; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
Nord J Psychiatry; 2017 Feb; 71(2):158-162. PubMed ID: 27796193
[TBL] [Abstract][Full Text] [Related]
17. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
[TBL] [Abstract][Full Text] [Related]
18. Association analysis for corticotropin releasing hormone polymorphisms with the risk of major depressive disorder and the response to antidepressants.
Chang HS; Won E; Lee HY; Ham BJ; Lee MS
Behav Brain Res; 2015 Oct; 292():116-24. PubMed ID: 26055202
[TBL] [Abstract][Full Text] [Related]
19. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
[TBL] [Abstract][Full Text] [Related]
20. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
